BACKGROUND: Coffee consumption has been associated with reduced risk for death in prospective cohort studies; however, data in nonwhites are sparse. OBJECTIVE: To examine the association of coffee consumption with risk for total and cause-specific death. DESIGN: The MEC (Multiethnic Cohort), a prospective population-based cohort study established between 1993 and 1996. SETTING: Hawaii and Los Angeles, California. PARTICIPANTS: 185 855 African Americans, Native Hawaiians, Japanese Americans, Latinos, and whites aged 45 to 75 years at recruitment. MEASUREMENTS: Outcomes were total and cause-specific mortality between 1993 and 2012. Coffee intake was assessed at baseline by means of a validated food-frequency questionnaire. RESULTS: 58 397 participants died during 3 195 484 person-years of follow-up (average follow-up, 16.2 years). Compared with drinking no coffee, coffee consumption was associated with lower total mortality after adjustment for smoking and other potential confounders (1 cup per day: hazard ratio [HR], 0.88 [95% CI, 0.85 to 0.91]; 2 to 3 cups per day: HR, 0.82 [CI, 0.79 to 0.86]; ≥4 cups per day: HR, 0.82 [CI, 0.78 to 0.87]; P for trend < 0.001). Trends were similar between caffeinated and decaffeinated coffee. Significant inverse associations were observed in 4 ethnic groups; the association in Native Hawaiians did not reach statistical significance. Inverse associations were also seen in never-smokers, younger participants (<55 years), and those who had not previously reported a chronic disease. Among examined end points, inverse associations were observed for deaths due to heart disease, cancer, respiratory disease, stroke, diabetes, and kidney disease. LIMITATION: Unmeasured confounding and measurement error, although sensitivity analysis suggested that neither was likely to affect results. CONCLUSION: Higher consumption of coffee was associated with lower risk for death in African Americans, Japanese Americans, Latinos, and whites. PRIMARY FUNDING SOURCE: National Cancer Institute.
BACKGROUND: Coffee consumption has been associated with reduced risk for death in prospective cohort studies; however, data in nonwhites are sparse. OBJECTIVE: To examine the association of coffee consumption with risk for total and cause-specific death. DESIGN: The MEC (Multiethnic Cohort), a prospective population-based cohort study established between 1993 and 1996. SETTING: Hawaii and Los Angeles, California. PARTICIPANTS: 185 855 African Americans, Native Hawaiians, Japanese Americans, Latinos, and whites aged 45 to 75 years at recruitment. MEASUREMENTS: Outcomes were total and cause-specific mortality between 1993 and 2012. Coffee intake was assessed at baseline by means of a validated food-frequency questionnaire. RESULTS: 58 397 participants died during 3 195 484 person-years of follow-up (average follow-up, 16.2 years). Compared with drinking no coffee, coffee consumption was associated with lower total mortality after adjustment for smoking and other potential confounders (1 cup per day: hazard ratio [HR], 0.88 [95% CI, 0.85 to 0.91]; 2 to 3 cups per day: HR, 0.82 [CI, 0.79 to 0.86]; ≥4 cups per day: HR, 0.82 [CI, 0.78 to 0.87]; P for trend < 0.001). Trends were similar between caffeinated and decaffeinated coffee. Significant inverse associations were observed in 4 ethnic groups; the association in Native Hawaiians did not reach statistical significance. Inverse associations were also seen in never-smokers, younger participants (<55 years), and those who had not previously reported a chronic disease. Among examined end points, inverse associations were observed for deaths due to heart disease, cancer, respiratory disease, stroke, diabetes, and kidney disease. LIMITATION: Unmeasured confounding and measurement error, although sensitivity analysis suggested that neither was likely to affect results. CONCLUSION: Higher consumption of coffee was associated with lower risk for death in African Americans, Japanese Americans, Latinos, and whites. PRIMARY FUNDING SOURCE: National Cancer Institute.
Authors: Neal D Freedman; Yikyung Park; Christian C Abnet; Albert R Hollenbeck; Rashmi Sinha Journal: N Engl J Med Date: 2012-05-17 Impact factor: 91.245
Authors: Erikka Loftfield; Meredith S Shiels; Barry I Graubard; Hormuzd A Katki; Anil K Chaturvedi; Britton Trabert; Ligia A Pinto; Troy J Kemp; Fatma M Shebl; Susan T Mayne; Nicolas Wentzensen; Mark P Purdue; Allan Hildesheim; Rashmi Sinha; Neal D Freedman Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-05-21 Impact factor: 4.254
Authors: Brandilyn A Peters; Marjorie L McCullough; Mark P Purdue; Neal D Freedman; Caroline Y Um; Susan M Gapstur; Richard B Hayes; Jiyoung Ahn Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-04-27 Impact factor: 4.254
Authors: Emily A Hu; Elizabeth Selvin; Morgan E Grams; Lyn M Steffen; Josef Coresh; Casey M Rebholz Journal: Am J Kidney Dis Date: 2018-03-20 Impact factor: 8.860
Authors: Erikka Loftfield; Marilyn C Cornelis; Neil Caporaso; Kai Yu; Rashmi Sinha; Neal Freedman Journal: JAMA Intern Med Date: 2018-08-01 Impact factor: 21.873
Authors: Yang Hu; Ming Ding; Chen Yuan; Kana Wu; Stephanie A Smith-Warner; Frank B Hu; Andrew T Chan; Jeffrey A Meyerhardt; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Mingyang Song Journal: Gastroenterology Date: 2017-11-20 Impact factor: 22.682
Authors: Song-Yi Park; Neal D Freedman; Christopher A Haiman; Loïc Le Marchand; Lynne R Wilkens; Veronica Wendy Setiawan Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-05-18 Impact factor: 4.254